Silence Therapeutics (SLN) Goodwill & Intangibles (2018 - 2026)
Silence Therapeutics recorded quarterly Goodwill & Intangibles of $10.6 million in Q1 2026, down 2.78% quarter-over-quarter from $10.9 million in Q4 2025, and down 2.97% year-over-year from $10.9 million in Q1 2025.
Silence Therapeutics' Goodwill & Intangibles history runs 9 years deep, the most recent figure standing at $10.6 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 2.97% year-over-year to $10.6 million; the TTM figure through Mar 2026 stood at $10.6 million (down 2.97% YoY), while the FY2025 annual figure was $10.9 million, up 12.42% from the prior year.
- Goodwill & Intangibles came in at $10.6 million for Q1 2026 at Silence Therapeutics, down from $10.9 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $10.9 million in Q2 2025 to a low of $9.4 million in Q3 2022.
- A 5-year average of $10.2 million and a median of $10.1 million in 2024 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles fell 12.44% in 2022 and increased 12.42% in 2025, its largest moves.
- Silence Therapeutics' Goodwill & Intangibles stood at $9.8 million in 2022, then increased by 3.21% to $10.1 million in 2023, then fell by 3.76% to $9.7 million in 2024, then gained by 12.42% to $10.9 million in 2025, then slipped by 2.78% to $10.6 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $10.6 million, $10.9 million, and $10.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.61 Mn |
| Dec 31, 2025 | 10.91 Mn |
| Sep 30, 2025 | 10.91 Mn |
| Jun 30, 2025 | 10.93 Mn |
| Mar 31, 2025 | 10.93 Mn |
| Dec 31, 2024 | 9.70 Mn |
| Sep 30, 2024 | 10.13 Mn |
| Jun 30, 2024 | 10.01 Mn |
| Mar 31, 2024 | 10.11 Mn |
| Dec 31, 2023 | 10.08 Mn |
| Sep 30, 2023 | 10.30 Mn |
| Jun 30, 2023 | 10.10 Mn |
| Mar 31, 2023 | 10.05 Mn |
| Dec 31, 2022 | 9.77 Mn |
| Sep 30, 2022 | 9.40 Mn |
| Jun 30, 2022 | 9.82 Mn |
| Mar 31, 2022 | 10.30 Mn |
| Dec 31, 2021 | 10.41 Mn |
| Sep 30, 2021 | 10.74 Mn |
| Jun 30, 2021 | 10.86 Mn |
| Dec 31, 2020 | 10.87 Mn |
| Jun 30, 2020 | 10.26 Mn |
| Dec 31, 2019 | 10.02 Mn |
| Jun 30, 2019 | 10.48 Mn |
| Dec 31, 2018 | 10.54 Mn |